Can you provide the average price target for ERASCA INC stock?
17 analysts have analysed ERAS and the average price target is 10.51 USD. This implies a price decrease of -23.33% is expected in the next year compared to the current price of 13.7025.
ERASCA INC (ERAS) Forecast, Price Target & Analyst Ratings
NASDAQ:ERAS • US29479A1088
Current stock price
13.7025 USD
+0.34 (+2.56%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ERASCA INC (ERAS).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 19, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.11
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$10.51
Upside
-23.33%
From current price of $13.70 to mean target of $10.51, Based on 17 analyst forecasts
Low
$2.02
Median
$11.22
High
$16.80
Price Target Revisions
1 Month
0.00%
3 Months
115.58%
Price Target Summary
17 Wall Street analysts provided a forecast for the next 12 months for ERAS. The average price target is 10.51 USD. This implies a price decrease of -23.33% is expected in the next year compared to the current price of 13.7025.
The average price target has been revised upward by 115.58% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
81.18%
ERAS was analyzed by 17 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about ERAS.
In the previous month the buy percentage consensus was at a similar level.
ERAS was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-16 | Guggenheim | Maintains | Buy -> Buy |
| 2026-03-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-03-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-03-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-03-06 | Clear Street | Maintains | Buy -> Buy |
| 2026-01-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-07 | Piper Sandler | Initiate | Overweight |
| 2025-12-09 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-14 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-16 | Stifel | Initiate | Buy |
| 2025-09-03 | B of A Securities | Downgrade | Buy -> Underperform |
| 2025-08-18 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-26 | Raymond James | Initiate | Outperform |
| 2025-03-21 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | B of A Securities | Upgrade | Neutral -> Buy |
| 2024-11-18 | Jefferies | Initiate | Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-25 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-10-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 19, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.11
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 0.78%
- Number of Analysts
- 12
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
2.73%
EPS (3 Months)
0.47%
Next Earnings Summary
ERAS is expected to report earnings on 3/19/2026. The consensus EPS estimate for the next earnings is -0.11 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 5,313.35% | N/A -32.59% | N/A 1,500.03% | N/A 112.08% | N/A 117.82% | N/A 49.28% | |||||||
| EBITDA YoY % growth | -12.98M | -36.96M -184.75% | -95.71M -158.96% | -142.81M -49.21% | -137.793M 3.51% | -148.582M -7.83% | N/A 2.32% | N/A -10.74% | N/A -11.33% | N/A -73.51% | N/A 30.63% | N/A 35.93% | N/A -67.03% | N/A 203.13% | N/A 165.10% | |
| EBIT YoY % growth | -13.29M | -37.5M -182.17% | -96.54M -157.44% | -145.45M -50.66% | -141.525M 2.70% | -152.387M -7.67% | N/A 3.64% | N/A -10.56% | N/A -21.74% | N/A -2.31% | N/A -42.03% | N/A 62.09% | N/A 229.65% | N/A 432.12% | N/A 71.50% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.96 16.33% | -0.83 57.65% | -0.74 10.84% | N/A 38.80% | N/A -4.95% | N/A -13.47% | N/A 5.91% | N/A -60.40% | N/A 27.94% | N/A 59.13% | N/A 400.00% | N/A 108.51% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 0.78% | -0.11 -2.00% | -0.12 -2.00% | -0.13 -14.36% | -0.12 -12.15% | -0.26 -132.73% | -0.27 -122.50% | -0.29 -134.33% |
| Revenue Q2Q % growth | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | -36.866M -15.54% | -34.088M 2.07% | -34.955M -20.47% | -36.047M -19.43% | -37.189M -0.88% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -35.783M -0.20% | -30.923M 13.21% | -28.895M 5.65% | -30.412M 6.56% | -39.974M -11.71% | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
8.33%
EPS Next 5 Year
-1.92%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
1.82%
EBIT Next 5 Year
-2.59%
ERASCA INC / ERAS Forecast FAQ
When does ERASCA INC (ERAS) report earnings?
ERASCA INC (ERAS) will report earnings on 2026-03-19, after the market close.
What are the consensus estimates for ERAS stock next earnings?
The consensus EPS estimate for the next earnings of ERASCA INC (ERAS) is -0.11 USD and the consensus revenue estimate is 0 USD.